Literature DB >> 9973559

Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone.

P J Hurd1, A J Whitmarsh, G S Baldwin, S M Kelly, J P Waltho, N C Price, B A Connolly, D P Hornby.   

Abstract

DNA duplexes in which the target cytosine base is replaced by 2-H pyrimidinone have previously been shown to bind with a significantly greater affinity to C5-cytosine DNA methyltransferases than unmodified DNA. Here, it is shown that 2-H pyrimidinone, when incorporated into DNA duplexes containing the recognition sites for M.HgaI-2 and M.MspI, elicits the formation of inhibitory covalent nucleoprotein complexes. We have found that although covalent complexes are formed between 2-H pyrimidinone-modified DNA and both M.HgaI-2 and M.MspI, the kinetics of complex formation are quite distinct in each case. Moreover, the formation of a covalent complex is still observed between 2-H pyrimidinone DNA and M.MspI in which the active-site cysteine residue is replaced by serine or threonine. Covalent complex formation between M.MspI and 2-H pyrimidinone occurs as a direct result of nucleophilic attack by the residue at the catalytic position, which is enhanced by the absence of the 4-amino function in the base. The substitution of the catalytic cysteine residue by tyrosine or chemical modification of the wild-type enzyme with N-ethylmaleimide, abolishes covalent interaction. Nevertheless the 2-H pyrimidinone-substituted duplex still binds to M.MspI with a greater affinity than a standard cognate duplex, since the 2-H pyrimidinone base is mis-paired with guanine. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973559     DOI: 10.1006/jmbi.1998.2491

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Characterisation of site-biased DNA methyltransferases: specificity, affinity and subsite relationships.

Authors:  Andrew R McNamara; Paul J Hurd; Alexander E F Smith; Kevin G Ford
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

2.  Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.

Authors:  Jurate Savickiene; Grazina Treigyte; Violeta Jonusiene; Renata Bruzaite; Veronika-Viktorija Borutinskaite; Ruta Navakauskiene
Journal:  Mol Cell Biochem       Date:  2011-08-13       Impact factor: 3.396

3.  Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases.

Authors:  L Zhou; X Cheng; B A Connolly; M J Dickman; P J Hurd; D P Hornby
Journal:  J Mol Biol       Date:  2002-08-23       Impact factor: 5.469

4.  Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.

Authors:  Jonathan C Cheng; Daniel J Weisenberger; Felicidad A Gonzales; Gangning Liang; Guo-Liang Xu; Ye-Guang Hu; Victor E Marquez; Peter A Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

5.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.

Authors:  Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2009-05-21       Impact factor: 4.872

6.  DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.

Authors:  Dana M van Bemmel; Adam S Brank; Ramon Eritja; Victor E Marquez; Judith K Christman
Journal:  Biochem Pharmacol       Date:  2009-05-23       Impact factor: 5.858

7.  Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.

Authors:  Christine Champion; Dominique Guianvarc'h; Catherine Sénamaud-Beaufort; Renata Z Jurkowska; Albert Jeltsch; Loïc Ponger; Paola B Arimondo; Anne-Laure Guieysse-Peugeot
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

8.  Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells.

Authors:  Peng Zhou; Yi Lu; Xing-Huai Sun
Journal:  Mol Vis       Date:  2012-01-10       Impact factor: 2.367

9.  Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2.

Authors:  Peng Zhou; Yi Lu; Xing-Huai Sun
Journal:  Mol Vis       Date:  2011-10-19       Impact factor: 2.367

10.  DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.

Authors:  Kazuaki Nakamura; Kazuko Aizawa; Kazuhiko Nakabayashi; Natsuko Kato; Junji Yamauchi; Kenichiro Hata; Akito Tanoue
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.